| scholarly article | Q13442814 |
| P50 | author | Luis Villacorta | Q42428596 |
| P2093 | author name string | Oren Rom | |
| Y Eugene Chen | |||
| Nicholas K H Khoo | |||
| P2860 | cites work | Molecular recognition of nitrated fatty acids by PPARγ | Q27651047 |
| Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids | Q27652730 | ||
| Interplay between oxidant species and energy metabolism | Q28383905 | ||
| Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acids | Q28386488 | ||
| Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase | Q28387540 | ||
| A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma | Q28593737 | ||
| Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators | Q30480974 | ||
| Reversible post-translational modification of proteins by nitrated fatty acids in vivo | Q33242770 | ||
| Nitro-oleic acid downregulates lipoprotein-associated phospholipase A2 expression via the p42/p44 MAPK and NFκB pathways | Q33585468 | ||
| Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice | Q33727789 | ||
| Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment | Q33746493 | ||
| Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions | Q33782620 | ||
| Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice. | Q33803709 | ||
| Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand | Q33849597 | ||
| Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension | Q33881508 | ||
| Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats | Q34021895 | ||
| Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality | Q34127761 | ||
| Bardoxolone methyl and kidney function in CKD with type 2 diabetes | Q34194954 | ||
| 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling | Q34208174 | ||
| Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. | Q34315432 | ||
| Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages | Q34316035 | ||
| Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease | Q34383685 | ||
| Endogenous ligands for nuclear receptors: digging deeper | Q34412495 | ||
| 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit | Q34516493 | ||
| Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179. | Q34568528 | ||
| Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism | Q34800018 | ||
| Electrophilic fatty acids regulate matrix metalloproteinase activity and expression. | Q34963415 | ||
| Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice. | Q35227098 | ||
| Convergence of biological nitration and nitrosation via symmetrical nitrous anhydride | Q35756214 | ||
| Nitro-fatty acid inhibition of triple negative breast cancer cell viability, migration, invasion and tumor growth | Q46257711 | ||
| Fatty acid transduction of nitric oxide signaling. Nitrolinoleic acid is a hydrophobically stabilized nitric oxide donor | Q46375494 | ||
| 'PPAR'ting ways with inflammation. | Q46715539 | ||
| Foundations of Immunometabolism and Implications for Metabolic Health and Disease | Q47772688 | ||
| Nitro-fatty acid pharmacokinetics in the adipose tissue compartment. | Q49352425 | ||
| Electrophilic fatty acid nitroalkenes regulate Nrf2 and NF-κB signaling:A medicinal chemistry investigation of structure-function relationships. | Q49358694 | ||
| In situ generation, metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation. | Q50056117 | ||
| The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease. | Q53095793 | ||
| Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells | Q35773071 | ||
| Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease | Q35791848 | ||
| Formation and signaling actions of electrophilic lipids | Q35804051 | ||
| Nitrated Fatty Acids Reverse Cigarette Smoke-Induced Alveolar Macrophage Activation and Inhibit Protease Activity via Electrophilic S-Alkylation | Q36000626 | ||
| Nitro-linolenic acid is a nitric oxide donor. | Q36013459 | ||
| Generation and esterification of electrophilic fatty acid nitroalkenes in triacylglycerides | Q36190263 | ||
| Nitro-fatty acid reaction with glutathione and cysteine. Kinetic analysis of thiol alkylation by a Michael addition reaction | Q36316709 | ||
| Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway | Q36319949 | ||
| Conjugated linoleic acid is a preferential substrate for fatty acid nitration | Q36492744 | ||
| Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands | Q36493003 | ||
| Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms. | Q36565424 | ||
| Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses | Q36567097 | ||
| Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts. | Q36687046 | ||
| PPARs and molecular mechanisms of transrepression | Q36791361 | ||
| Nitroalkenes suppress lipopolysaccharide-induced signal transducer and activator of transcription signaling in macrophages: a critical role of mitogen-activated protein kinase phosphatase 1. | Q36796547 | ||
| Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine. | Q36920628 | ||
| Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury | Q36956739 | ||
| Modulation of nitro-fatty acid signaling: prostaglandin reductase-1 is a nitroalkene reductase | Q37132192 | ||
| PPARgamma and its ligands: therapeutic implications in cardiovascular disease. | Q37179467 | ||
| PPARγ signaling and metabolism: the good, the bad and the future | Q37407887 | ||
| Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice | Q37439729 | ||
| Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid | Q37446099 | ||
| Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion | Q37467857 | ||
| Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites | Q37524364 | ||
| Evaluation of 10-Nitro Oleic Acid Bio-Elimination in Rats and Humans | Q37560854 | ||
| Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity | Q37591231 | ||
| Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD). | Q37622525 | ||
| Nitro-Oleic Acid Reduces J774A.1 Macrophage Oxidative Status and Triglyceride Mass: Involvement of Paraoxonase2 and Triglyceride Metabolizing Enzymes | Q38762193 | ||
| Studies on the substrate and stereo/regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases | Q41818160 | ||
| Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. | Q42135532 | ||
| Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion | Q42250704 | ||
| Nitro-oleic acid inhibits angiotensin II-induced hypertension | Q42428542 | ||
| Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition. | Q42620946 | ||
| Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells | Q44055051 | ||
| PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation. | Q46158421 | ||
| P577 | publication date | 2018-03-22 | |
| P1433 | published in | Nitric Oxide | Q7041392 |
| P1476 | title | Inflammatory signaling and metabolic regulation by nitro-fatty acids. |
| Q92572638 | A FABP4-PPARγ signaling axis regulates human monocyte responses to electrophilic fatty acid nitroalkenes |
| Q90052360 | Editorial: Nitro-fatty acids: novel drug candidates for the co-treatment of atherosclerosis and nonalcoholic fatty liver disease |
| Q90463086 | Electrophilic fatty acid nitroalkenes are systemically transported and distributed upon esterification to complex lipids |
| Q64290118 | Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice |
| Q92166620 | Pharmacokinetic and Pharmacodynamic Effects of Oral CXA-10, a Nitro Fatty Acid, After Single and Multiple Ascending Doses in Healthy and Obese Subjects |
| Q92757606 | Post-Translational Modification of Proteins Mediated by Nitro-Fatty Acids in Plants: Nitroalkylation |
| Q91844945 | STING palmitoylation as a therapeutic target |
Search more.